Toggle menu

ExPRES SEPSIS

Start date:
January 2014
End date:
July 2015
Co-ordinated by:
University of Edinburgh & NHS Lothian

Early Prediction of Severe Sepsis

Aim

To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis

Trial Design

A Prospective, multi-centre cohort observational study

Chief Investigator

Professor Tim Walsh, Critical Care Research Group

Local PI

Professor Tim Walsh

Research Team

  • EMERGE Research team
  • Critical Care Research Group
  • Rossi Lab, MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected sepsis

Further information

http://www.ccm.mvm.ed.ac.uk/

http://www.cir.ed.ac.uk/

Research Team

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Julia Grahamslaw

Lead Research Nurse

Related news

Dip Dazzles at RCEM

Dip Dazzles at RCEM

9 Oct 2015 | Rachel O'Brien

Read more

More EMERGE Trials

Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world

Read more

Garfield-VTE

Global Anticoagulant Registry In the FIELD – Venous Thromboembolic Events

Patients commonly present to the Emergency Department with epistaxsis (nose bleed). Standard first aid measures such as applying pressure can often stem bleeding however in more severe cases of epistaxsis further treatment is required.

Read more

NoPac

Novel Use of Tranexamic Acid to Reduce the Need for Nasal Packing

MAPP2

The Markers and Paracetamol Poisoning Study 2